Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
0.3150
-0.0060 (-1.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,612,374
Open
0.3210
Bid (Size)
0.3105 (1)
Ask (Size)
0.3200 (8)
Prev. Close
0.3210
Today's Range
0.2850 - 0.3210
52wk Range
0.2850 - 22.80
Shares Outstanding
10,299,385
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 01, 2024
Via
Benzinga
Performance
YTD
-97.46%
-97.46%
1 Month
-79.00%
-79.00%
3 Month
-26.45%
-26.45%
6 Month
-95.63%
-95.63%
1 Year
-98.47%
-98.47%
More News
Read More
12 Health Care Stocks Moving In Monday's Intraday Session
September 30, 2024
Via
Benzinga
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 18, 2024
Via
ACCESSWIRE
Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
September 17, 2024
Via
ACCESSWIRE
Looking Into Applied DNA Sciences's Recent Short Interest
September 10, 2024
Via
Benzinga
Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan
September 04, 2024
Via
ACCESSWIRE
Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 23, 2024
Via
ACCESSWIRE
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
September 17, 2024
Via
ACCESSWIRE
Why Applied DNA Sciences (APDN) Stock Is Skyrocketing
September 11, 2024
Via
Benzinga
Applied DNA Launches Mpox Clade I and Clade II Testing Service
September 11, 2024
Via
ACCESSWIRE
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
September 03, 2024
Via
Benzinga
Looking Into Applied DNA Sciences's Recent Short Interest
August 21, 2024
Via
Benzinga
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
August 08, 2024
Via
ACCESSWIRE
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?
August 23, 2024
Via
Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 21, 2024
Via
Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 19, 2024
Via
ACCESSWIRE
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
August 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
August 19, 2024
Via
Benzinga
APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024
August 09, 2024
Via
InvestorPlace
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
August 07, 2024
Via
ACCESSWIRE
CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
July 29, 2024
Via
ACCESSWIRE
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit
July 29, 2024
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.